This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Japan

Hiroaki Suzuki
Key Account Manager Japan at Vetter Pharma International Japan
Speaker

Profile

He has 17+ years in pharmaceutical industry since his start in management consulting at ZS Associates, a US based global management consulting firm focusing on sales and marketing. He has joined Vetter from 2015 since its opening of Tokyo office to extend reach to Japanese customers and has successfully guided number of compounds from Japanese pharma companies to global / Japan market. His role as Vetter’s representative in Japan has been to establish strong presence in Japan market.

As part of Vetter positioning strategy, he has also been an active member at Medical Device Committee of Japan PDA, taking a leading role in its major activities the last seven years.

Prior to joining to ZS associates after graduation from McDonough School of Business at Georgetown University in 2007, he has worked for 16 years at Furukawa Electric Co., Ltd. as research scientist in two focused areas in power cable / accessories and optical communication device including 1 year stint as guest scientist at National Research Council (NRC) Canada. He has successfully launched more than 7 products to local / global markets which still operate.

He holds MBA degree from Georgetown university, and Bachelor degree in chemical engineering from Waseda University.

Agenda Sessions

  • Chairperson’s Remarks: Track 1

    10:55am
  • Chairperson's Remarks: Track 1

    1:40pm